180 related articles for article (PubMed ID: 11974481)
21. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases.
Bowne WB; Lee B; Wong WD; Ben-Porat L; Shia J; Cohen AM; Enker WE; Guillem JG; Paty PB; Weiser MR
Dis Colon Rectum; 2005 May; 48(5):897-909. PubMed ID: 15785892
[TBL] [Abstract][Full Text] [Related]
22. Cancer in the oropharynx: cost calculation of different treatment modalities for controlled primaries, relapses and grade III/IV complications.
Nijdam W; Levendag P; Noever I; Groot CU; Agthoven Mv
Radiother Oncol; 2005 Oct; 77(1):65-72. PubMed ID: 16213619
[TBL] [Abstract][Full Text] [Related]
23. Early results of intersphincteric resection for patients with very low rectal cancer: an active approach to avoid a permanent colostomy.
Saito N; Ono M; Sugito M; Ito M; Morihiro M; Kosugi C; Sato K; Kotaka M; Nomura S; Arai M; Kobatake T
Dis Colon Rectum; 2004 Apr; 47(4):459-66. PubMed ID: 14978613
[TBL] [Abstract][Full Text] [Related]
24. [Cost analysis of clinical treatment of polytrauma patients].
Ruchholtz S; Nast-Kolb D; Waydhas C; Stuber R; Lewan U; Schweiberer L
Chirurg; 1995 Jul; 66(7):684-92. PubMed ID: 7671756
[TBL] [Abstract][Full Text] [Related]
25. Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy.
Akbari RP; Paty PB; Guillem JG; Weiser MR; Temple LK; Minsky BD; Saltz L; Wong WD
Dis Colon Rectum; 2004 Jul; 47(7):1136-44. PubMed ID: 15164245
[TBL] [Abstract][Full Text] [Related]
26. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
[TBL] [Abstract][Full Text] [Related]
27. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
[TBL] [Abstract][Full Text] [Related]
28. Surgery for locally recurrent rectal cancer.
Boyle KM; Sagar PM; Chalmers AG; Sebag-Montefiore D; Cairns A; Eardley I
Dis Colon Rectum; 2005 May; 48(5):929-37. PubMed ID: 15785880
[TBL] [Abstract][Full Text] [Related]
29. The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer.
Temple LK; Bacik J; Savatta SG; Gottesman L; Paty PB; Weiser MR; Guillem JG; Minsky BD; Kalman M; Thaler HT; Schrag D; Wong WD
Dis Colon Rectum; 2005 Jul; 48(7):1353-65. PubMed ID: 15868235
[TBL] [Abstract][Full Text] [Related]
30. Participation of the general gynecologist in surgical staging of endometrial cancer: analysis of cost and perioperative outcomes.
Hoekstra A; Singh DK; Garb M; Arekapudi S; Rademaker A; Lurain JR
Gynecol Oncol; 2006 Dec; 103(3):897-901. PubMed ID: 16814370
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of resection of stage IV rectal cancer with mesorectal excision.
Law WL; Chu KW
J Surg Oncol; 2006 Jun; 93(7):523-8. PubMed ID: 16705728
[TBL] [Abstract][Full Text] [Related]
32. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
33. Preoperative tegafur suppositories for resectable rectal cancer: phase II trial.
Ohwada S; Sato Y; Izumi M; Kashiwabara K; Ogawa T; Hamada K; Kawate S; Nakamura S
Dis Colon Rectum; 2006 Oct; 49(10):1602-10. PubMed ID: 17036208
[TBL] [Abstract][Full Text] [Related]
34. Laparoscopic pelvic autonomic nerve-preserving surgery for patients with lower rectal cancer after chemoradiation therapy.
Liang JT; Lai HS; Lee PH
Ann Surg Oncol; 2007 Apr; 14(4):1285-7. PubMed ID: 17235719
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for anastomotic leakage after resection for rectal cancer.
Eberl T; Jagoditsch M; Klingler A; Tschmelitsch J
Am J Surg; 2008 Oct; 196(4):592-8. PubMed ID: 18571620
[TBL] [Abstract][Full Text] [Related]
36. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer.
Martling A; Cedermark B; Johansson H; Rutqvist LE; Holm T
Br J Surg; 2002 Aug; 89(8):1008-13. PubMed ID: 12153626
[TBL] [Abstract][Full Text] [Related]
37. Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.
Meyerhardt JA; Tepper JE; Niedzwiecki D; Hollis DR; Schrag D; Ayanian JZ; O'Connell MJ; Weeks JC; Mayer RJ; Willett CG; MacDonald JS; Benson AB; Fuchs CS
J Clin Oncol; 2004 Jan; 22(1):166-74. PubMed ID: 14701779
[TBL] [Abstract][Full Text] [Related]
38. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
[TBL] [Abstract][Full Text] [Related]
39. Anastomotic leakage following anterior resection for rectal cancer.
Kanellos I; Vasiliadis K; Angelopoulos S; Tsachalis T; Pramateftakis MG; Mantzoros I; Betsis D
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s79-81. PubMed ID: 15655652
[TBL] [Abstract][Full Text] [Related]
40. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
